Scammers routinely impersonate Microsoft online. New research breaks down how the brand is used in phishing and why it still works.
Sanofi is scrapping plans to get one of its more advanced experimental medicines approved for a certain kind of multiple sclerosis, following negative results from a clinical trial disclosed Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback